omega-n-methylarginine has been researched along with Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuma, H; Katsuoka, Y; Kubota, T; Miura-Takeda, S; Miyoshi-Higashino, M; Nomi, H; Takahashi, T; Tashiro-Yamaji, J; Ueda, H; Yamamoto, Y; Yoshida, R | 1 |
1 other study(ies) available for omega-n-methylarginine and Leukemia
Article | Year |
---|---|
Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Fas Ligand Protein; Graft Rejection; Heart Transplantation; Leukemia; Macrophage-1 Antigen; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Knockout; Neoplasm Transplantation; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Perforin; Pore Forming Cytotoxic Proteins; Receptors, Antigen, T-Cell, alpha-beta; Skin Transplantation; Transplantation, Homologous | 2007 |